Search: onr:"swepub:oai:DiVA.org:oru-65200" >
Breast cancer in Et...
-
Hadgu, EndaleDepartment of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(author)
Breast cancer in Ethiopia : evidence for geographic difference in the distribution of molecular subtypes in Africa
- Article/chapterEnglish2018
Publisher, publication year, extent ...
-
2018-02-14
-
BioMed Central,2018
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:oru-65200
-
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-65200URI
-
https://doi.org/10.1186/s12905-018-0531-2DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Funding Agencies:Addis Ababa University, School of Graduate Studies Addis Ababa University, thematic research group "clinico-epidemiological characterization of breast cancer in Ethiopia" Armauer Hansen Research Institute (AHRI) Swedish International Developmental Agency (SIDA)
-
BACKGROUND: Breast cancer is a heterogeneous disease with several morphological and molecular subtypes. Widely accepted molecular classification system uses assessment of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and proliferation marker Ki67. Few studies have been conducted on the incidence and molecular types of breast cancer in Sub-Saharan Africa. Previous studies mainly from Western and Central Africa, showed breast cancer to occur at younger ages and to present with aggressive features, such as high-grade, advanced stage and triple-negative phenotype (negative for ER, PR and HER2). Limited data from East Africa including Ethiopia however shows hormone receptor negative tumors to account for a lower proportion of all breast cancers than has been reported from elsewhere in Africa.METHODS: In this study from Tikur Anbessa Specialized Hospital, 114 breast cancer patients diagnosed between 2012 and 2015 were enrolled. ER, PR, Ki67 and HER2 receptor status were assessed using immunohistochemistry from tissue microarrays. FISH was used for assessment of gene amplification in all equivocal tumor samples and for confirmation in HER2-enriched cases.RESULTS: The distribution of molecular subtypes was: Luminal A: 40%; Luminal B: 26%; HER2-enriched: 10%; TNBC: 23%. ER were positive in 65% of all tumors and 43% the cases were positive for PR. There was statistically significant difference in median age at diagnosis between the molecular subtypes (P < 0.05). There was a bimodal distribution of molecular subtypes in different age ranges with Luminal B subtype being more common at younger ages (median = 36) and Luminal A subtype more prevalent at older ages (median = 42). There were no statistically significant differences in tumor grade, histology, and stage between the molecular subtypes of breast cancer.CONCLUSION: The present study detected Luminal A breast cancer to be the most common subtype and reveals a relatively low rate of hormone receptor negative and TNBC. Our findings and results from other East African studies suggest geographic variability in the distribution of the molecular subtypes of breast cancer in Africa and hence have important clinical and policy implications for breast cancer control and treatment in Ethiopia.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Seifu, DanielDepartment of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(author)
-
Tigneh, WondemagegnhuDepartment of Oncology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(author)
-
Bokretsion, YonasDepartment of Pathology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(author)
-
Bekele, AbebeDepartment of Surgery, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(author)
-
Abebe, MarkosArmauer Hansen research Institute (AHRI), Addis Ababa, Ethiopia
(author)
-
Sollie, ThomasDept of Laboratory Medicine, Örebro University Hospital, Örebro, Sweden
(author)
-
Merajver, Sofia D.University of Michigan Comprehensive Cancer Center, Ann Arbor MI, USA
(author)
-
Karlsson, Christina,1968-Örebro universitet,Institutionen för hälsovetenskaper(Swepub:oru)ckn
(author)
-
Karlsson, Mats,1960-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Laboratory Medicine, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden(Swepub:oru)mskn
(author)
-
Department of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, EthiopiaDepartment of Oncology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia
(creator_code:org_t)
Related titles
-
In:BMC Women's Health: BioMed Central18:11472-6874
Internet link
Find in a library
To the university's database
- By the author/editor
-
Hadgu, Endale
-
Seifu, Daniel
-
Tigneh, Wondemag ...
-
Bokretsion, Yona ...
-
Bekele, Abebe
-
Abebe, Markos
-
show more...
-
Sollie, Thomas
-
Merajver, Sofia ...
-
Karlsson, Christ ...
-
Karlsson, Mats, ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
BMC Women's Heal ...
- By the university
-
Örebro University